Europe Ocular Drug Delivery Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)

No. of Pages: 152    |    Report Code: TIPRE00025762    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Ocular Drug Delivery Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. Europe Ocular Drug Delivery Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. Europe Ocular Drug Delivery Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Advances in ocular drug delivery technologies
  • 5.1.2 Growth in demand for non-invasive drug delivery systems
5.2 Market Opportunities
  • 5.2.1 Expansion in ophthalmic drug delivery market
  • 5.2.2 Growth in demand for effective ocular treatments
5.3 Future Trends
  • 5.3.1 Development of novel ocular drug delivery systems
  • 5.3.2 Rise in demand for sustained-release eye treatments
5.4 Impact of Drivers and Restraints

6. Europe Ocular Drug Delivery Market Regional Analysis

6.1 Europe Ocular Drug Delivery Market Overview
6.2 Europe Ocular Drug Delivery Market Revenue 2019-2028 (US$ Million)
6.3 Europe Ocular Drug Delivery Market Forecast Analysis

7. Europe Ocular Drug Delivery Market Analysis – by Technology

7.1 Implantable Ocular Drug Delivery Systems
  • 7.1.1 Overview
  • 7.1.2 Implantable Ocular Drug Delivery Systems: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Particulate Drug Delivery Systems
  • 7.2.1 Overview
  • 7.2.2 Particulate Drug Delivery Systems: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Nano-Particle Drug Delivery System
  • 7.3.1 Overview
  • 7.3.2 Nano-Particle Drug Delivery System: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Ocular Drug Delivery Market Analysis – by Formulation Type

8.1 Liposomes and Nanoparticles
  • 8.1.1 Overview
  • 8.1.2 Liposomes and Nanoparticles: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Solution
  • 8.2.1 Overview
  • 8.2.2 Solution: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Emulsion
  • 8.3.1 Overview
  • 8.3.2 Emulsion: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Suspension
  • 8.4.1 Overview
  • 8.4.2 Suspension: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ointment
  • 8.5.1 Overview
  • 8.5.2 Ointment: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Ocular Drug Delivery Market Analysis – by Disease Type

9.1 Glaucoma
  • 9.1.1 Overview
  • 9.1.2 Ointment: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Diabetic Retinopathy
  • 9.2.1 Overview
  • 9.2.2 Ointment: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Dry Eye Syndrome
  • 9.3.1 Overview
  • 9.3.2 Ointment: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Macular Degeneration
  • 9.4.1 Overview
  • 9.4.2 Ointment: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Cataract
  • 9.5.1 Overview
  • 9.5.2 Ointment: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Diabetic Macular Edema
  • 9.6.1 Overview
  • 9.6.2 Ointment: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Ocular Drug Delivery Market – Europe Analysis

10.1 Europe
  • 10.1.1 Europe Ocular Drug Delivery Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 Europe Ocular Drug Delivery Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 UK: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 UK: Europe Ocular Drug Delivery Market Breakdown, by Technology
    • 10.1.1.1.2 UK: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
    • 10.1.1.1.3 UK: Europe Ocular Drug Delivery Market Breakdown, by Disease Type
  • 10.1.1.2 Germany: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Germany: Europe Ocular Drug Delivery Market Breakdown, by Technology
    • 10.1.1.2.2 Germany: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
    • 10.1.1.2.3 Germany: Europe Ocular Drug Delivery Market Breakdown, by Disease Type
  • 10.1.1.3 France: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 France: Europe Ocular Drug Delivery Market Breakdown, by Technology
    • 10.1.1.3.2 France: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
    • 10.1.1.3.3 France: Europe Ocular Drug Delivery Market Breakdown, by Disease Type
  • 10.1.1.4 Russia: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.4.1 Russia: Europe Ocular Drug Delivery Market Breakdown, by Technology
    • 10.1.1.4.2 Russia: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
    • 10.1.1.4.3 Russia: Europe Ocular Drug Delivery Market Breakdown, by Disease Type
  • 10.1.1.5 Italy: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.5.1 Italy: Europe Ocular Drug Delivery Market Breakdown, by Technology
    • 10.1.1.5.2 Italy: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
    • 10.1.1.5.3 Italy: Europe Ocular Drug Delivery Market Breakdown, by Disease Type
  • 10.1.1.6 Rest of Europe: Europe Ocular Drug Delivery Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.6.1 Rest of Europe: Europe Ocular Drug Delivery Market Breakdown, by Technology
    • 10.1.1.6.2 Rest of Europe: Europe Ocular Drug Delivery Market Breakdown, by Formulation Type
    • 10.1.1.6.3 Rest of Europe: Europe Ocular Drug Delivery Market Breakdown, by Disease Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Europe Ocular Drug Delivery Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AbbVie Inc.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Bausch Health Companies Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Novartis AG
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Clearside Biomedical, Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Alimera Sciences, Inc.
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 GRAYBUG VISION, INC
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - E Market

  1. AbbVie Inc.                                              
  2. Bausch Health Companies Inc.            
  3. Novartis AG                                            
  4. Clearside Biomedical, Inc                      
  5. Alimera Sciences, Inc.                           
  6. GRAYBUG VISION, INC                      
europe-ocular-drug-delivery-market